Fitbit Inc. is developing a method to detect irregular heart rhythm in time through a partnership with the Bristol-Myers Squibb-Pfizer Alliance, while the handheld maker seeks to match a feature available from rival Apple Inc (AAPL.O ) To see.
Fitbit has been deepening into the healthcare industry and in August, it teamed up with the Singapore government to provide trackers and fitness services in a health program that the company said could reach up to one million users. (reut.rs/2TWAkpG)
According to Thursday's agreement, the company's devices will carry software that will help detect atrial fibrillation – the most common type of irregular heartbeat – after approval by the US Food and Drug Administration.
Atrial fibrillation is a condition associated with irregular heart rhythm that increases the risk of stroke and is generally prevalent in people over 65 years of age.
About 2.7 to 6 million people suffer from the disease in the United States, according to the Center for Disease Control and Prevention.